Merck Sharp

Drug firm Glenmark Pharmaceuticals on Thursday said it is evaluating legal options after the Delhi High Court restrained it from manufacturing and selling generic version of Merck Sharp and Dohme's anti-diabetes medicines Januvia and Janumet.

In a relief for US drug major Merck Sharp and Dohme (MSD), the Delhi High Court on Wednesday restrained Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.

In a relief for US drug major Merck Sharp and Dohme (MSD), Delhi High Court today restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.

The Supreme Court on Wednesday stayed till April 28 the order of Delhi High Court barring Indian pharmaceuticals major Glenmark from making, marketing or selling its anti-diabetes medicines in which US drug major Merck Sharp and Dohme (MSD) has claimed a patent right.

US stocks edged higher on Friday following a payroll report that suggested a sharp rebound in economic activity early in the second quarter.

Corporate czars like Anil Ambani, Sunil Bharti Mittal and business houses including Tata came under intense judicial scanner for scam-related cases in 2013 with Subrata Roy Sahara facing the toughest time in Supreme Court which restrained him from leaving India.

The American drug major is involved in a patent row with Glenmark which has recently come out with the two medicines in alleged violation of intellectual property rights (IPR) used in its drugs Januvia and Janumet.

The Delhi High Court today posted April 12 as the date of hearing for an appeal filed by US pharmaceuticals major Merck Sharp and Dohme (MSD) against the single judge bench order refusing to restrain Indian firm Glenmark from manufacturing and selling anti-diabetes drugs Zita and Zita-Met.

US pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High Court challenging its single bench order refusing to grant interim relief to it on a patent row against Indian firm Glenmark Pharmaceuticals.

Drug firm Dr Reddy's Laboratories today said it has launched its generic Finasteride tablets used for treating male pattern hair loss in the American market.

Drug firm Glenmark Pharmaceuticals on Thursday said it is evaluating legal options after the Delhi High Court restrained it from manufacturing and selling generic version of Merck Sharp and Dohme's anti-diabetes medicines Januvia and Janumet.

In a relief for US drug major Merck Sharp and Dohme (MSD), the Delhi High Court on Wednesday restrained Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.

In a relief for US drug major Merck Sharp and Dohme (MSD), Delhi High Court today restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.

The Supreme Court on Wednesday stayed till April 28 the order of Delhi High Court barring Indian pharmaceuticals major Glenmark from making, marketing or selling its anti-diabetes medicines in which US drug major Merck Sharp and Dohme (MSD) has claimed a patent right.

US stocks edged higher on Friday following a payroll report that suggested a sharp rebound in economic activity early in the second quarter.

Corporate czars like Anil Ambani, Sunil Bharti Mittal and business houses including Tata came under intense judicial scanner for scam-related cases in 2013 with Subrata Roy Sahara facing the toughest time in Supreme Court which restrained him from leaving India.

The American drug major is involved in a patent row with Glenmark which has recently come out with the two medicines in alleged violation of intellectual property rights (IPR) used in its drugs Januvia and Janumet.

The Delhi High Court today posted April 12 as the date of hearing for an appeal filed by US pharmaceuticals major Merck Sharp and Dohme (MSD) against the single judge bench order refusing to restrain Indian firm Glenmark from manufacturing and selling anti-diabetes drugs Zita and Zita-Met.

US pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High Court challenging its single bench order refusing to grant interim relief to it on a patent row against Indian firm Glenmark Pharmaceuticals.

Drug firm Dr Reddy's Laboratories today said it has launched its generic Finasteride tablets used for treating male pattern hair loss in the American market.